Hirsutism: Evaluation and Treatment

    October 2017 in “ JOGC/Journal of obstetrics and gynaecology Canada ”
    Kimberly Liu, Tarek Motan, Paul Claman
    Studysummary This review discusses the causes and management of hirsutism and suggests improvement can be achieved with a combination of hair removal, suppression of androgen production, and lifestyle changes over 6 to 9 months.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jogc.com →
    Discuss this study in the Community →

    Research cited in this study 44

    1. Clinician vs Self-Ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome JAMA dermatology · 2016
    2. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1 Endocrine Practice · 2015
    3. Adjuvant Eflornithine to Maintain IPL-Induced Hair Reduction in Women with Facial Hirsutism: A Randomized Controlled Trial Journal of the European Academy of Dermatology and Venereology · 2015
    4. Interventions for Hirsutism (Excluding Laser and Photoepilation Therapy Alone) Cochrane library · 2015
    5. Hirsutism: An Evidence-Based Treatment Update American Journal of Clinical Dermatology · 2014
    6. Hirsutism: Diagnosis and Treatment Arquivos Brasileiros De Endocrinologia E Metabologia · 2014
    7. Update on Idiopathic Hirsutism: Diagnosis and Treatment Acta Clinica Belgica · 2013
    8. An Approach to the Patient with Hirsutism ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2012
    9. Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society Human reproduction update · 2011
    10. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society The Journal of Clinical Endocrinology & Metabolism · 2010
    11. Hirsutism: Diagnosis and Management Gender Medicine · 2010
    12. Visually Scoring Hirsutism Human reproduction update · 2009
    13. Spironolactone Versus Placebo or in Combination with Steroids for Hirsutism and/or Acne Cochrane library · 2009
    14. Congenital Adrenal Hyperplasia: A Review of 21-Hydroxylase Deficiency and Diagnostic Challenges Dermato-endocrinology · 2009
    15. Androgen Dependence of Hirsutism, Acne, and Alopecia in Women Medicine · 2009
    16. The Clinical Evaluation of Hirsutism Dermatologic therapy · 2008
    17. Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Meta-Analyses of Randomized Controlled Trials The Journal of Clinical Endocrinology & Metabolism · 2008
    18. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology & Metabolism · 2008
    19. Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Meta-Analyses of Randomized Controlled Trials ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2008
    20. Helpful Diagnostic Markers of Steroidogenesis for Defining Hyperandrogenemia in Hirsute Women Steroids · 2007
    21. Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus The Journal of Clinical Endocrinology & Metabolism · 2007
    22. A Randomized Bilateral Vehicle-Controlled Study of Eflornithine Cream Combined with Laser Treatment Versus Laser Treatment Alone for Facial Hirsutism in Women Journal of the American Academy of Dermatology · 2007
    23. Drug-Induced Hair Disorders Current Drug Safety · 2006
    24. Diagnosis of Hyperandrogenism: Clinical Criteria Best Practice & Research Clinical Endocrinology & Metabolism · 2006
    25. Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred Because of Clinical Hyperandrogenism The Journal of Clinical Endocrinology and Metabolism · 2006
    26. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients The Journal of Clinical Endocrinology and Metabolism · 2004
    27. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome Fertility and Sterility · 2004
    28. Cyproterone Acetate for Hirsutism Cochrane library · 2003
    29. The Evaluation and Management of Hirsutism Obstetrics and gynecology (New York. 1953. Online)/Obstetrics and gynecology · 2003
    30. Comparison of Diane 35 and Diane 35 Plus Finasteride in the Treatment of Hirsutism Fertility and Sterility · 2001
    31. Topical Eflornithine: Efficacy in Reducing Unwanted Facial Hair Growth in Women American journal of clinical dermatology · 2001
    32. Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial The Journal of Clinical Endocrinology and Metabolism · 2000
    33. A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism The Journal of Clinical Endocrinology and Metabolism · 1999
    34. Ruby Laser Treatment for Hirsutism: Clinical Response and Patient Tolerance British journal of dermatology/British journal of dermatology, Supplement · 1998
    35. Comparison of Cyproterone Acetate Plus Ethinyl Estradiol and Finasteride in the Treatment of Hirsutism Journal of Endocrinological Investigation · 1998
    36. Laser-Assisted Hair Removal Dermatologic Clinics · 1997
    37. Gonadotrophin-Releasing Hormone Agonist Therapy for Hirsutism Is as Effective as High Dose Cyproterone Acetate but Results in a Longer Remission Human reproduction · 1997
    38. Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up Fertility and Sterility · 1996
    39. Electrolysis: Observations from 13 Years and 140,000 Hours of Experience Journal of the American Academy of Dermatology · 1995
    40. A Prospective Randomized Trial Comparing Finasteride to Spironolactone in the Treatment of Hirsute Women The Journal of Clinical Endocrinology and Metabolism · 1995
    41. Clinical and Hormonal Effects of the 5 Alpha-Reductase Inhibitor Finasteride in Idiopathic Hirsutism The Journal of Clinical Endocrinology and Metabolism · 1994
    42. Effects of Finasteride, a 5 Alpha-Reductase Inhibitor, on Circulating Androgens and Gonadotropin Secretion in Hirsute Women The Journal of Clinical Endocrinology and Metabolism · 1994
    43. Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism: A Randomized Controlled Trial Fertility and Sterility · 1994
    44. Cyproterone Acetate for Severe Hirsutism: Results of a Double-Blind Dose-Ranging Study Clinical endocrinology · 1991

    Related research 4

    1. Current Aspects of Polycystic Ovary Syndrome: A Literature Review Revista Da Associacao Medica Brasileira · 2016
    2. Caring for Women with Polycystic Ovary Syndrome The Nurse Practitioner · 2016
    3. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    4. Screening for Diabetes in Women with Polycystic Ovary Syndrome Canadian Medical Association Journal · 2007